TW200801033A - Process for the manufacture of peptide facilitators of reverse cholesterol transport - Google Patents

Process for the manufacture of peptide facilitators of reverse cholesterol transport

Info

Publication number
TW200801033A
TW200801033A TW095138946A TW95138946A TW200801033A TW 200801033 A TW200801033 A TW 200801033A TW 095138946 A TW095138946 A TW 095138946A TW 95138946 A TW95138946 A TW 95138946A TW 200801033 A TW200801033 A TW 200801033A
Authority
TW
Taiwan
Prior art keywords
cholesterol transport
reverse cholesterol
facilitators
peptide
manufacture
Prior art date
Application number
TW095138946A
Other languages
English (en)
Inventor
Jagadish C Sircar
James J Mencel
Original Assignee
Avanir Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avanir Pharmaceuticals filed Critical Avanir Pharmaceuticals
Publication of TW200801033A publication Critical patent/TW200801033A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
TW095138946A 2005-11-04 2006-10-23 Process for the manufacture of peptide facilitators of reverse cholesterol transport TW200801033A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73335205P 2005-11-04 2005-11-04

Publications (1)

Publication Number Publication Date
TW200801033A true TW200801033A (en) 2008-01-01

Family

ID=37907410

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138946A TW200801033A (en) 2005-11-04 2006-10-23 Process for the manufacture of peptide facilitators of reverse cholesterol transport

Country Status (4)

Country Link
US (1) US20070105783A1 (zh)
AR (1) AR056766A1 (zh)
TW (1) TW200801033A (zh)
WO (1) WO2007055873A2 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2609810T3 (es) * 2012-05-31 2017-04-24 Theravance Biopharma R&D Ip, Llc Inhibidores de neprilisina donadores de óxido nítrico

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2052595T3 (es) * 1986-12-15 1994-07-16 Inst Nat Sante Rech Med Nuevos derivados peptidicos y su aplicacion en especial en terapeutica.
US4952562A (en) * 1989-09-29 1990-08-28 Rorer Pharmaceutical Corporation Anti-thrombotic peptides and pseudopeptides
WO1999003880A1 (en) * 1997-07-15 1999-01-28 Novo Nordisk A/S Nociceptin analogues
US6821774B1 (en) * 1999-06-18 2004-11-23 Cv Therapeutics, Inc. Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
FR2820435B1 (fr) * 2001-02-05 2004-02-27 Genfit S A Procedes d'identification de composes modulant le transport inverse du cholesterol
EP1388537A1 (en) * 2001-05-15 2004-02-11 Taisho Pharmaceutical Co., Ltd Arginine derivatives
WO2004094471A2 (en) * 2003-04-22 2004-11-04 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
WO2006049597A1 (en) * 2004-10-27 2006-05-11 Avanir Pharmaceuticals Amino acid-derived compounds as modulators of the reverse cholesterol transport

Also Published As

Publication number Publication date
US20070105783A1 (en) 2007-05-10
AR056766A1 (es) 2007-10-24
WO2007055873A2 (en) 2007-05-18
WO2007055873A3 (en) 2007-10-18

Similar Documents

Publication Publication Date Title
GB0412753D0 (en) Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis
IL188019A0 (en) Novel peptides for use in the treatment of obesity
MX2009005460A (es) (s)-n-estereoisomeros de analogos de 7,8-saturados-4,5-epoxi-morfi nano.
TW200602042A (en) Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
LT1854477T (lt) Peptidai, slopinantys plazmos kalikreiną, skirti naudoti oftalmologinių sutrikimų gydymui
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
PL2061485T3 (pl) Peptydy EV576 do zastosowania w leczeniu zespołu Guillaina-Barrégo
EP1922345A4 (en) PROCESS FOR THE PREPARATION OF COPOLYMER-1
IL196565A0 (en) Physiologically active polypeptide polymer micelle having protein enclosed therein and process for the production thereof
WO2007111661A3 (en) Human antibodies specific for gastrin materials and methods
MX2009012920A (es) Compuestos heptaciclicos y usos farmaceuticos de los mismos para la prevencion y tratamiento de diabetes y sindrome metabolico.
IL189270A0 (en) Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
IL189104A (en) Pharmaceutical preparation containing lasalazide or sodium balasalazide for use in the treatment of gastrointestinal disorders.
PT2078038E (pt) Agentes tensioativos reconstituídos apresentando propriedades melhoradas
HK1083296A1 (en) Enteral composition for the prevention and/or treatment of sepsis
WO2006020430A8 (en) Novel composition and methods for the treatment of immune related disease
TW200503747A (en) Peptide mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
HK1123507A1 (en) Composition for preventing or treating damages of the mucosa in the gastrointestinal tracts
SI1838716T1 (sl) Olanzapin pamoat dihidrat
TW200801033A (en) Process for the manufacture of peptide facilitators of reverse cholesterol transport
TW200603794A (en) Small molecules for treatment of hypercholesterolemia and related diseases
EP2029176A4 (en) VIRAL CAPSID PROTEINS AND PEPTIDES OR COMPOSITIONS THEREOF FOR TREATING PATHOLOGICAL DISORDER
IL182692A (en) Use of vlp and amyloid-beta peptide for the manufacture of pharmaceutical compositions for the treatment of dementia
TW200603795A (en) Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
SI1854477T1 (sl) Peptidi, ki inhibirajo plazma kalikrein za uporabo pri zdravljenju očesnih motenj